Brief: Kintara Therapeutics Announces Review Of Strategic Alternatives
Dec 7 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS ANNOUNCES REVIEW OF STRATEGIC
ALTERNATIVES
* KINTARA THERAPEUTICS INC: INITIATED A PROCESS TO EXPLORE
AND
REVIEW A RANGE OF STRATEGIC ALTERNATIVES FOCUSED ON MAXIMIZING
STOCKHOLDER VALUE.
* KINTARA THERAPEUTICS INC - KINTARA HAS ENGAGED LADENBURG
THALMANN & CO. INC. TO ACT AS FINANCIAL ADVISOR FOR THIS
PROCESS.
* KINTARA THERAPEUTICS - CAN BE NO ASSURANCE THAT THIS
EXPLORATION
OF STRATEGIC ALTERNATIVES WILL RESULT IN CO ENTERING OR
COMPLETING ANY TRANSACTION
Source text for Eikon: ID:nPn8j3Tq4a
Further company coverage: KTRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.